MoonLake Immunotherapeutics (MLTX)
46.76
+0.34
(+0.73%)
USD |
NASDAQ |
Nov 01, 16:00
46.48
-0.28
(-0.60%)
After-Hours: 20:00
MoonLake Immunotherapeutics Price to Book Value: 5.648 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 5.648 |
| October 31, 2024 | 5.607 |
| October 30, 2024 | 5.677 |
| October 29, 2024 | 5.821 |
| October 28, 2024 | 5.804 |
| October 25, 2024 | 5.641 |
| October 24, 2024 | 5.580 |
| October 23, 2024 | 5.627 |
| October 22, 2024 | 5.798 |
| October 21, 2024 | 5.921 |
| October 18, 2024 | 5.911 |
| October 17, 2024 | 5.807 |
| October 16, 2024 | 5.933 |
| October 15, 2024 | 5.798 |
| October 14, 2024 | 5.906 |
| October 11, 2024 | 5.911 |
| October 10, 2024 | 5.677 |
| October 09, 2024 | 5.760 |
| October 08, 2024 | 6.021 |
| October 07, 2024 | 6.249 |
| October 04, 2024 | 6.677 |
| October 03, 2024 | 6.281 |
| October 02, 2024 | 6.259 |
| October 01, 2024 | 6.247 |
| September 30, 2024 | 6.09 |
| Date | Value |
|---|---|
| September 27, 2024 | 5.967 |
| September 26, 2024 | 6.205 |
| September 25, 2024 | 6.137 |
| September 24, 2024 | 6.554 |
| September 23, 2024 | 6.692 |
| September 20, 2024 | 6.527 |
| September 19, 2024 | 6.487 |
| September 18, 2024 | 6.415 |
| September 17, 2024 | 6.159 |
| September 16, 2024 | 6.037 |
| September 13, 2024 | 6.177 |
| September 12, 2024 | 6.165 |
| September 11, 2024 | 5.607 |
| September 10, 2024 | 5.629 |
| September 09, 2024 | 5.648 |
| September 06, 2024 | 5.558 |
| September 05, 2024 | 5.505 |
| September 04, 2024 | 5.726 |
| September 03, 2024 | 5.594 |
| August 30, 2024 | 5.652 |
| August 29, 2024 | 5.735 |
| August 28, 2024 | 5.654 |
| August 27, 2024 | 5.667 |
| August 26, 2024 | 5.817 |
| August 23, 2024 | 6.012 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.052
Minimum
Jun 30 2022
53.83
Maximum
Jun 27 2023
8.813
Average
6.144
Median
Price to Book Value Benchmarks
| Novartis AG | 5.047 |
| AC Immune SA | 2.162 |
| CRISPR Therapeutics AG | 2.182 |
| Addex Therapeutics Ltd | 0.8125 |
| NLS Pharmaceutics Ltd | -- |
Price to Book Value Related Metrics
| Price | 46.76 |
| Earnings Yield | -1.90% |
| Market Cap | 2.941B |